BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ling Q, Xu X, Wang B, Li L, Zheng S. The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut? Transplantation. 2016;100:808-813. [PMID: 26910326 DOI: 10.1097/tp.0000000000001111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Al-jarhi UM, Mogawer S, Mohsen M, Dessouky NMTE, Gouda MA, Rakha M. Recipient IL28B genotype CT is a predictor of new onset diabetes mellitus in liver transplant patients with chronic hepatitis C. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-01015-6] [Reference Citation Analysis]
2 Zhao Y, Xing H. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. J Diabetes Res 2017;2017:5625371. [PMID: 28352640 DOI: 10.1155/2017/5625371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
3 Huang HT, Zhang XY, Zhang C, Ling Q, Zheng SS. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile. World J Gastroenterol 2020; 26(19): 2374-2387 [PMID: 32476799 DOI: 10.3748/wjg.v26.i19.2374] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Tabibian JH, Kenderian SS. The Microbiome and Immune Regulation After Transplantation. Transplantation 2017;101:56-62. [PMID: 27517729 DOI: 10.1097/TP.0000000000001444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
5 Liu FC, Lin HT, Lin JR, Yu HP. Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients. Ther Clin Risk Manag 2017;13:1043-51. [PMID: 28860788 DOI: 10.2147/TCRM.S142348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Jiménez-Pérez M, González-Grande R, Omonte Guzmán E, Amo Trillo V, Rodrigo López JM. Metabolic complications in liver transplant recipients. World J Gastroenterol 2016; 22(28): 6416-6423 [PMID: 27605877 DOI: 10.3748/wjg.v22.i28.6416] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
7 Peruhova M, Peshevska-Sekulovska M, Velikova T. Interactions between human microbiome, liver diseases, and immunosuppression after liver transplant. World J Immunol 2021; 11(2): 11-16 [DOI: 10.5411/wji.v11.i2.11] [Reference Citation Analysis]
8 Ling Q, Xie H, Li J, Liu J, Cao J, Yang F, Wang C, Hu Q, Xu X, Zheng S. Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver Transplantation. Am J Transplant. 2017;17:255-264. [PMID: 27458792 DOI: 10.1111/ajt.13984] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
9 Terto SV, Araújo ST, Negreiros FDDS, Brasil BMBL, da Cunha GH, Rodrigues AB, de Carvalho MMD, Gadelha DD, Carioca AAF, Oliveira Fernandes V, Montenegro Júnior RM. Risk Factors Associated With New-Onset Diabetes After Liver Transplant: A Case Control Study. Transplant Proc 2019;51:1956-61. [PMID: 31303408 DOI: 10.1016/j.transproceed.2019.04.030] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Han Y, Jiang X, Ling Q, Wu L, Wu P, Tang R, Xu X, Yang M, Zhang L, Zhu W, Wang B, Li L. Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice. Front Med 2019;13:471-81. [PMID: 31054103 DOI: 10.1007/s11684-019-0686-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Bajaj JS, Kakiyama G, Cox IJ, Nittono H, Takei H, White M, Fagan A, Gavis EA, Heuman DM, Gilles HC, Hylemon P, Taylor-Robinson SD, Legido-Quigley C, Kim M, Xu J, Williams R, Sikaroodi M, Pandak WM, Gillevet PM. Alterations in gut microbial function following liver transplant. Liver Transpl 2018;24:752-61. [PMID: 29500907 DOI: 10.1002/lt.25046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
12 Chen Z, Yuan W, Liu T, Huang D, Xiang L. Bioinformatics analysis of hepatic gene expression profiles in type 2 diabetes mellitus. Exp Ther Med 2019;18:4303-12. [PMID: 31772629 DOI: 10.3892/etm.2019.8092] [Reference Citation Analysis]
13 Zhang C, Chen K, Wei R, Fan G, Cai X, Xu L, Cen B, Wang J, Xie H, Zheng S, Xu X. The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis. Signal Transduct Target Ther 2020;5:23. [PMID: 32296037 DOI: 10.1038/s41392-020-0105-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]